- •
Diffusion-weighted imaging reflects the tissue cellularity of musculoskeletal tumors, and a low apparent diffusion coefficient value (<1.1) is seen in more cellular and more aggressive tumors, but does not reliably differentiate malignant from benign tumors.
- •
Pharmacokinetic value changes in dynamic contrast-enhanced MR imaging after treatment that reflects decreased vessel permeability (Ktrans, Kep) and tumor blood volume (Ve and Vp) reflect and correlate with therapeutic response.
- •
High choline
MR Imaging of Pediatric Musculoskeletal Tumors:: Recent Advances and Clinical Applications
Section snippets
Key points
Pediatric musculoskeletal tumors
Childhood sarcomas, including rhabdomyosarcoma (RMS) and other soft tissue sarcomas, Ewing sarcoma (EWS), and osteosarcoma, comprise approximately 10% of childhood malignancies. Pediatric sarcomas are generally treated with a multimodal therapeutic approach that includes some combination of systemic chemotherapy, surgical resection, and/or radiotherapy. Survival for localized pediatric sarcomas improved dramatically after the introduction of dose-intensive multiagent chemotherapy regimens, but
Role of conventional MR imaging techniques
MR imaging is a primary imaging modality in pediatric musculoskeletal tumors. In pediatric bone and soft tissue tumors, MR imaging starts with large field-of-view studies to include joint to joint using short-tau inversion recovery (STIR) and T1WI sequences and provides information for local staging of the primary tumor (T) and nodal staging (N). According to the American Joint Committee on Cancer staging system, malignant bone tumors are defined as T1 (tumor size ≤8 cm), T2 (tumor size >8 cm),
Diffusion-Weighted Imaging
DW imaging exploits the degree of water diffusion (Brownian motion) around the cells,39 represented by a quantitative variable, the apparent diffusion coefficient (ADC) value (×10−3 mm2/s). As opposed to the free environment, water diffusion is restricted in tissues because of several barriers, including cell membranes, organelles, other proteins, and so forth. Thus, restricted diffusion is observed in highly organized, fibrotic, fatty, proteinaceous, cellular tissues or tumors, whereas
Summary
To conclude, many novel MR imaging approaches are now available to exploit tumor cellularity, perfusion, oxygenation, and heterogeneity in the realm of pediatric musculoskeletal tumor imaging. More scientific work with greater interdisciplinary collaboration between physicists, computer specialists, and physicians is needed to optimally use these different techniques. Finally, their incremental value over conventional imaging in providing more functional and physiologic information can help
References (155)
- et al.
Impact of RANK signalling on survival and chemotherapy response in osteosarcoma
Pathology
(2014) - et al.
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma
Cell Rep
(2014) - et al.
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Cell
(2011) - et al.
Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis
J Pediatr Surg
(2014) - et al.
Assessment of musculoskeletal malignancies with functional MR imaging
Magn Reson Imaging Clin N Am
(2016) - et al.
The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis
Eur J Radiol
(2016) - et al.
Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T
Eur J Radiol
(2015) - et al.
The diagnostic value of diffusion-weighted magnetic resonance imaging in soft tissue abscesses
Eur J Radiol
(2011) - et al.
Diffusion tensor magnetic resonance imaging of the normal breast
Magn Reson Imaging
(2010) - et al.
Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors
Eur J Radiol
(2005)
Imaging of tumor angiogenesis for radiologists--part 1: biological and technical basis
Curr Probl Diagn Radiol
Value of dynamic magnetic resonance imaging in preoperative evaluation of pediatric osteosarcoma
Egypt J Radiol Nucl Med
Pediatric fibroblastic and myofibroblastic tumors: a pictorial review
Radiographics
De novo assessment of pediatric musculoskeletal soft tissue tumors: beyond anatomic imaging
Pediatrics
The role of whole-body MRI in pediatric oncology
J Pediatr Hematol Oncol
Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions
Eur Radiol
Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1
Clin Cancer Res
Pediatric sarcomas are targetable by MR-guided high intensity focused ultrasound (MR-HIFU): anatomical distribution and radiological characteristics
Pediatr Blood Cancer
Noninvasive therapy for osteoid osteoma: a prospective developmental study with MR imaging-guided high-intensity focused ultrasound
Radiology
Outcomes for children and adolescents with cancer: challenges for the twenty-first century
J Clin Oncol
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
Cancer
Outcome of patients with recurrent osteosarcoma enrolled in seven phase II trials through children's cancer group, pediatric oncology group, and children's oncology group: learning from the past to move forward
J Clin Oncol
Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the children's oncology group
J Clin Oncol
Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the children's oncology group
J Clin Oncol
Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): a report from the Children’s Oncology Group (COG)
J Clin Oncol
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group
J Clin Oncol
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival–a report from the Children's Oncology Group
J Clin Oncol
Pazopanib therapy for desmoid tumors in adolescent and young adult patients
Pediatr Blood Cancer
Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis)
J Clin Oncol
Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study
Eur Radiol
Osteoid osteoma: MR-guided focused ultrasound for entirely noninvasive treatment
Radiology
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program
Clin Cancer Res
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
J Clin Oncol
The genomic landscape of pediatric Ewing sarcoma
Cancer Discov
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
Cancer Discov
Imaging of bone tumors and tumor-like lesions (techniques and applications)
Insights into quantitative diffusion-weighted MRI for musculoskeletal tumor imaging
Am J Roentgenol
Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques
Radiology
Can MR imaging be used to predict tumor grade in soft-tissue sarcoma?
Radiology
Local staging of soft-tissue sarcoma: emphasis on assessment of neurovascular encasement-value of MR imaging in 174 confirmed cases
Radiology
Lymph node metastasis in soft tissue sarcoma in an extremity
Clin Orthop Relat Res
Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T
Radiology
Bone marrow metastases: T2-weighted dixon spin-echo fat images can replace T1-weighted spin-echo images
Radiology
Frequency and severity of acute allergic-like reactions to intravenously administered gadolinium-based contrast media in children
Invest Radiol
Gadolinium and nephrogenic systemic fibrosis: an update
Pediatr Nephrol
Investigations on the theory of the Brownian movement
Molecular diffusion, tissue microdynamics and microstructure
NMR Biomed
Diffusion MR imaging: clinical applications
AJR Am J Roentgenol
Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review
Skeletal Radiol
Cited by (5)
Qualitative and Quantitative MRI Techniques for the Evaluation of Musculoskeletal Neoplasms
2022, Seminars in RoentgenologyCitation Excerpt :More cells leave less room for the water molecules to move around, leading to a lower ADC value - indicating more cellularity or a more proteinaceous, fibrotic, or organized tissue. Conversely, greater free movement of water molecules, and a subsequent higher ADC value, points to a less cellular, necrotic, or treated mass or tissue (Fig. 7).20 DWI and ADC are helpful in determining type of enhancing soft tissue mass, for example, very low ADC can be seen in round cell tumors to the tune of 0.6-0.8 mm2/s, high-grade sarcomas have ADC values of 0.7-1.1 mm2/s and lower grade and benign tumors have ADC >1.2-2.0 mm2/s. Although certainly helpful, the role of DWI and ADC values in the primary assessment of tumors to differentiate between malignant and benign lesions in isolation remains difficult due to overlap in the ADC values (Fig. 8).26,27
Musculoskeletal Tumors (Osteosarcoma and Ewing’s Sarcoma)
2021, Pediatric Surgery: General Pediatric Surgery, Tumors, Trauma and TransplantationQuantitative imaging examinations in childhood and adolescence
2020, Monatsschrift fur Kinderheilkunde
Dr H.K. Kim serves as consultant with Medpace. Dr A. Chhabra serves as consultant with ICON Medical and receives royalties from Jaypee and Wolters. Drs M-J. Lee, J.G. Pressey, and C.L. Dumoulin have nothing to disclose.